Marybeth Nelson
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunodeficiency and Autoimmune Disorders
Papers in
- Genetics 12
- Chronic Lymphocytic Leukemia Research 12
-
- Chronic Myeloid Leukemia Treatments 5
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Martín C. Mihm (1 shared paper)James P. Allison (1 shared paper)Alan J. Korman (1 shared paper)Christine Canning (1 shared paper)Michael T. Jaklitsch (1 shared paper)Donna Neuberg (1 shared paper)Teresa C. Chen (1 shared paper)Nikhil H. Ramaiya (1 shared paper)
- Journals
- Blood (9 papers)Journal of Clinical Oncology (3 papers)Proceedings of the National Academy of Sciences (1 paper)Leukemia & lymphoma (1 paper)PubMed (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Marybeth Nelson
17 papers receiving 786 citations
Marybeth Nelson's Hit Papers
Peers
Comparison fields: 5 of 46
- Genetics 242
- Immunology 419
- Oncology 383
- Pathology and Forensic Medicine 178
- Hematology 99
Countries citing papers authored by Marybeth Nelson
This map shows the geographic impact of Marybeth Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marybeth Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marybeth Nelson more than expected).
Fields of papers citing papers by Marybeth Nelson
This network shows the impact of papers produced by Marybeth Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marybeth Nelson. The network helps show where Marybeth Nelson may publish in the future.
Co-authors
The 25 scholars most cited alongside Marybeth Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients Hit paper breakdown → | 2008 | 489 |
| 2 | 2009 | 192 | |
| 3 | 2008 | 37 | |
| 4 | Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice. | 1989 | 28 |
| 5 | 2008 | 10 | |
| 6 | 2008 | 9 | |
| 7 | 2008 | 6 | |
| 8 | 2007 | 5 | |
| 9 | 2008 | 4 | |
| 10 | 2007 | 3 | |
| 11 | 2009 | 3 | |
| 12 | 2007 | 3 | |
| 13 | 2008 | 2 | |
| 14 | 2007 | 1 | |
| 15 | 2007 | 1 | |
| 16 | 2009 | 1 | |
| 17 | 2009 | 1 |
About Marybeth Nelson
Marybeth Nelson is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 17 papers that have together received 795 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Protein Degradation and Inhibitors (2 papers), Multiple Myeloma Research and Treatments (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Genetics (242 citations), Immunology (419 citations), Oncology (383 citations), Pathology and Forensic Medicine (178 citations) and Hematology (99 citations). Marybeth Nelson has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Martín C. Mihm, James P. Allison, Alan J. Korman, Christine Canning, Michael T. Jaklitsch, Donna Neuberg, Teresa C. Chen, Nikhil H. Ramaiya, Darryl A. Oble and Sara E. Russell. Their work appears in journals such as Blood, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Leukemia & lymphoma and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.